Annexin Pharmaceuticals AB (OSTO:ANNX) Price-to-Tangible-Book : 17.50 (As of May. 27, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Price-to-Tangible-Book?

As of today (2024-05-27), Annexin Pharmaceuticals AB's share price is kr0.28. Annexin Pharmaceuticals AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr0.02. Hence, Annexin Pharmaceuticals AB's Price to Tangible Book Ratio of today is 17.50.

The historical rank and industry rank for Annexin Pharmaceuticals AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:ANNX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.77 Med: 3.31 Max: 419.44
Current: 14

During the past 9 years, Annexin Pharmaceuticals AB's highest Price to Tangible Book Ratio was 419.44. The lowest was 0.77. And the median was 3.31.

OSTO:ANNX's Price-to-Tangible-Book is ranked worse than
93.04% of 1221 companies
in the Biotechnology industry
Industry Median: 2.8 vs OSTO:ANNX: 14.00

A closely related ratio is called PB Ratio. As of today, Annexin Pharmaceuticals AB's share price is kr0.28. Annexin Pharmaceuticals AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr0.02. Hence, Annexin Pharmaceuticals AB's P/B Ratio of today is 16.47.

Annexin Pharmaceuticals AB Price-to-Tangible-Book Historical Data

The historical data trend for Annexin Pharmaceuticals AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annexin Pharmaceuticals AB Price-to-Tangible-Book Chart

Annexin Pharmaceuticals AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.91

6.28

2.97

5.19

4.87

Annexin Pharmaceuticals AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															9.04	13.37	419.44	4.87	14.62

Competitive Comparison of Annexin Pharmaceuticals AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Annexin Pharmaceuticals AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annexin Pharmaceuticals AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annexin Pharmaceuticals AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Annexin Pharmaceuticals AB's Price-to-Tangible-Book falls into.

Annexin Pharmaceuticals AB Price-to-Tangible-Book Calculation

Annexin Pharmaceuticals AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	0.28	/	0.016
	=	17.50

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Annexin Pharmaceuticals AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Annexin Pharmaceuticals AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Annexin Pharmaceuticals AB (OSTO:ANNX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

Q91:Germany

Address

Norrtullsgatan 6, Stockholm, SWE, SE-113 29

Website

https://www.annexinpharma.com

Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.